Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth
- 13 January 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (576)
- https://doi.org/10.1126/scitranslmed.abc6245
Abstract
Inflammation contributes to nearly 4 million global premature births annually. Here, we used a mouse model of intrauterine inflammation to test clinically used formulations, as well as engineered nanoformulations, for the prevention of preterm birth (PTB). We observed that neither systemic 17a-hydroxyprogesterone caproate (Makena) nor vaginal progesterone gel (Crinone) was sufficient to prevent inflammation-induced PTB, consistent with recent clinical trial failures. However, we found that vaginal delivery of mucoinert nanosuspensions of histone deacetylase (HDAC) inhibitors, in some cases with the addition of progesterone, prevented PTB and resulted in delivery of live pups exhibiting neurotypical development. In human myometrial cells in vitro, the P4/HDAC inhibitor combination both inhibited cell contractility and promoted the anti-inflammatory action of P4 by increasing progesterone receptor B stability. Here, we demonstrate the use of vaginally delivered drugs to prevent intrauterine inflammation–induced PTB resulting in the birth of live offspring in a preclinical animal model.Keywords
Funding Information
- National Science Foundation (DGE-1746891)
- National Institutes of Health (P30CA006973)
- National Institutes of Health (UL1TR003098)
- National Institutes of Health (S10RR026824)
- National Cancer Institute (U54-CA209992)
- Burroughs Wellcome Fund (1015020)
- National Center for Advancing Translational Sciences (UL1TR003098)
- John Templeton Foundation (61329)
- Hartwell Foundation
This publication has 90 references indexed in Scilit:
- Myometrial immune cells contribute to term parturition, preterm labour and post‐partum involution in miceJournal of Cellular and Molecular Medicine, 2012
- Is Wetter Better? An Evaluation of Over-the-Counter Personal Lubricants for Safety and Anti-HIV-1 ActivityPLOS ONE, 2012
- Progesterone Receptor-A and -B Have Opposite Effects on Proinflammatory Gene Expression in Human Myometrial Cells: Implications for Progesterone Actions in Human Pregnancy and ParturitionJournal of Clinical Endocrinology & Metabolism, 2012
- Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injuryInternational Journal of Developmental Neuroscience, 2011
- The Molecular Mechanisms of Cervical Ripening Differ between Term and Preterm BirthEndocrinology, 2011
- Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization–embryo transfer cycles: a prospective randomized studyFertility and Sterility, 2010
- miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and laborProceedings of the National Academy of Sciences of the United States of America, 2010
- Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicleAmerican Journal of Obstetrics and Gynecology, 2010
- Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at termjpme, 2010
- Hyaluronan and its binding proteins during cervical ripening and parturition: Dynamic changes in size, distribution and temporal sequenceMatrix Biology, 2008